Value of working with an Academic Research Organisation
Working with ICTU’s network of investigators offers the potential of keeping a finger on the pulse of key study findings that may alter development plans. It also enables pharmaceutical companies to collaborate with Imperial’s investigators many of whom are key opinion leaders in their field. ICTU’s links with scientific researchers across the campus provides a real opportunity to integrate ‘bench to bedside medicine’ in designing innovative trials.
A smart alternative to doing clinical trials in-house:
The majority of studies conducted in-house by pharmaceutical companies fail to complete on time and on budget. Some of the reasons for this include
- Choosing investigators or sites based on relationship factors rather than objective evaluation of a site’s ability to recruit patients and deliver a study to the standard required
- Failing to conduct rigorous feasibility testing or review performance in previous studies
A smart alternative to outsourcing studies to a Contract Research Organisation (CRO)
Outsourcing a study to a CRO can result in important missed opportunities:
- Building key relationships with the people with the most experience of your compound in clinical practice
- Early academic insight on the potential role for new compounds in treatment guidelines